162 related articles for article (PubMed ID: 19212293)
21. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.
Goubau C; Wilschanski M; Skalická V; Lebecque P; Southern KW; Sermet I; Munck A; Derichs N; Middleton PG; Hjelte L; Padoan R; Vasar M; De Boeck K
Thorax; 2009 Aug; 64(8):683-91. PubMed ID: 19318346
[TBL] [Abstract][Full Text] [Related]
22. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.
Cohn JA; Friedman KJ; Noone PG; Knowles MR; Silverman LM; Jowell PS
N Engl J Med; 1998 Sep; 339(10):653-8. PubMed ID: 9725922
[TBL] [Abstract][Full Text] [Related]
23. Non-allergic asthma as a CFTR-related disorder.
Schulz A; Tümmler B
J Cyst Fibros; 2016 Sep; 15(5):641-4. PubMed ID: 26526220
[TBL] [Abstract][Full Text] [Related]
24. Normal sweat chloride test does not rule out cystic fibrosis.
Başaran AE; Karataş-Torun N; Maslak İC; Bingöl A; Alper ÖM
Turk J Pediatr; 2017; 59(1):68-70. PubMed ID: 29168366
[TBL] [Abstract][Full Text] [Related]
25. N1303K and IVS8-5T, clinical presentation within a family with atypical cystic fibrosis.
Van Hoorenbeeck K; Storm K; van den Ende J; Biervliet M; Desager KN
J Cyst Fibros; 2007 May; 6(3):220-2. PubMed ID: 17127107
[TBL] [Abstract][Full Text] [Related]
26. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
[TBL] [Abstract][Full Text] [Related]
27. Genotype analysis and phenotypic manifestations of children with intermediate sweat chloride test results.
Desmarquest P; Feldmann D; Tamalat A; Boule M; Fauroux B; Tournier G; Clement A
Chest; 2000 Dec; 118(6):1591-7. PubMed ID: 11115444
[TBL] [Abstract][Full Text] [Related]
28. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM
Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754
[TBL] [Abstract][Full Text] [Related]
29. Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and cystic fibrosis phenotype.
McKone EF; Velentgas P; Swenson AJ; Goss CH
J Cyst Fibros; 2015 Sep; 14(5):580-6. PubMed ID: 25660278
[TBL] [Abstract][Full Text] [Related]
30. Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis.
Stewart B; Zabner J; Shuber AP; Welsh MJ; McCray PB
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):899-903. PubMed ID: 7533604
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic problems in cystic fibrosis - specific characteristics of a group of infants and young children diagnosed positive through neonatal screening, in whom cystic fibrosis had not been diagnosed.
Woś H; Sankiewicz-Szkółka M; Więcek S; Kordys-Darmolińska B; Grzybowska-Chlebowczyk U; Kniażewska M
Dev Period Med; 2015; 19(1):25-31. PubMed ID: 26003067
[TBL] [Abstract][Full Text] [Related]
32. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis.
Sharer N; Schwarz M; Malone G; Howarth A; Painter J; Super M; Braganza J
N Engl J Med; 1998 Sep; 339(10):645-52. PubMed ID: 9725921
[TBL] [Abstract][Full Text] [Related]
33. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
[TBL] [Abstract][Full Text] [Related]
34. Cystic-fibrosis-like disease unrelated to the cystic fibrosis transmembrane conductance regulator.
Mekus F; Ballmann M; Bronsveld I; Dörk T; Bijman J; Tümmler B; Veeze HJ
Hum Genet; 1998 May; 102(5):582-6. PubMed ID: 9654209
[TBL] [Abstract][Full Text] [Related]
35. Cystic fibrosis presenting as acute pancreatitis and obstructive azoospermia in a young adult male with a novel mutation in the CFTR gene.
Conway SP; Peckham DG; Chu CE; Ellis LA; Ahmed M; Taylor GR
Pediatr Pulmonol; 2002 Dec; 34(6):491-5. PubMed ID: 12422349
[TBL] [Abstract][Full Text] [Related]
36. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
[TBL] [Abstract][Full Text] [Related]
37. Mutations of the cystic fibrosis gene and intermediate sweat chloride levels in children.
Lebecque P; Leal T; De Boeck C; Jaspers M; Cuppens H; Cassiman JJ
Am J Respir Crit Care Med; 2002 Mar; 165(6):757-61. PubMed ID: 11897640
[TBL] [Abstract][Full Text] [Related]
38. Borderline sweat test: Utility and limits of genetic analysis for the diagnosis of cystic fibrosis.
Seia M; Costantino L; Paracchini V; Porcaro L; Capasso P; Coviello D; Corbetta C; Torresani E; Magazzù D; Consalvo V; Monti A; Costantini D; Colombo C
Clin Biochem; 2009 May; 42(7-8):611-6. PubMed ID: 19318035
[TBL] [Abstract][Full Text] [Related]
39. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
[TBL] [Abstract][Full Text] [Related]
40. Screening for cystic fibrosis: the importance of using the correct tools.
Shah U; Moatter T
J Ayub Med Coll Abbottabad; 2006; 18(1):7-10. PubMed ID: 16773960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
